Motley Fool Staff

OPEC’s cut was solid for a few months, but as time goes on, more and more members are slipping past their agreements.

Bempedoic acid could cut bad cholesterol in a big way and could be up for approval as early as 2019.

The executive behind the most commonly used Alzheimer's drug is working on a follow-up that will be used in combination.

Getting one drug through the FDA's gantlet is hard enough for a small pharmaceutical company. Aurinia Pharma CEO Richard Glickman is well on his way to a second.

The founder of stedi.com comes on "Rule Breaker Investing" to talk about some of the most exciting trends in the market today.

Your household fiscal health is just one piece in a much bigger puzzle, but it’s a piece that holistically interacts with all the other parts and should be treated that way.

Employees need the help, and employers will benefit from providing it. But exactly what types of assistance should they focus on?

Believe it or not, the top answer is the same across every demographic, but there are distinct generational issues as well.

You may think the answer to that first question is so obvious it doesn’t need to be explicitly states -- but that’s because so many people have their own definitions.

Stranger things have happened in the battle for online retail market share.

The company has compensated for poor stock returns with a sizable yield and annual special dividend payments.

Listener Ashish thinks that global conditions may be making U.S. equities naturally more attractive -- and valuable -- than they were in times past.

Listener Jamie, a recent graduate, asks a classic question of financial priorities.

Listener Martin asks a question that really cuts to the heart of the Foolish investing philosophy: How do you limit the number of losers in your portfolio?

Listener Jeff is a novice investor with limited amounts of cash to put into his portfolio each month.

Listener Gerry questions the correlation between the management style at the top and the bottom line for investors.

When it comes to investing and financial planning, you should never take advice at face value.

As competition gets tighter, it’s getting harder and harder for grocery stores to grow their earnings and beat the market in growth.

Investors in new IPOs lack a significant amount of management commentary, and they miss out on some big keys to a company's performance.

Investors should wait at least six months after an IPO to buy in given the huge amount of risk for losses.